NDC 61133-5449 - PenAqua Sol-G
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61133-5449
- Package NDCs from labels
- 61133-5449-1
- Manufacturer
- Bimeda Inc. | Constant Irwindale
- Effective date
- 2024-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PenAqua Sol-G - Bimeda Inc. | Constant Irwindale | Bimeda Inc. | Constant Irwindale | 2024-01-30 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PENICILLIN G POTASSIUM | ACTIVE INGREDIENT | VL775ZTH4C | PENAQUA SOL-G (PENICILLIN G POTASSIUM) POWDER, FOR SOLUTION [BIMEDA INC., DIVISION OF CROSS VETPHARM GROUP] | 8 | |
| PENICILLIN G | ACTIVE MOIETY | Q42T66VG0C | PENAQUA SOL-G (PENICILLIN G POTASSIUM) POWDER, FOR SOLUTION [BIMEDA INC., DIVISION OF CROSS VETPHARM GROUP] | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PENICILLIN G POTASSIUM | PENICILLIN G | Baxter Healthcare Corporation | 9e58122f-5c75-4905-a774-d3a4dae4ff8c | 2026-07-24 | Warnings, Adverse reactions | VL775ZTH4C |
| PENICILLIN G POTASSIUM | PENICILLIN G POTASSIUM | HF Acquisition Co LLC, DBA HealthFirst | 56ab659e-ad28-028f-e063-6394a90a6943 | 2026-07-15 | Warnings, Adverse reactions | VL775ZTH4C |
| PENICILLIN G POTASSIUM | PENICILLIN G POTASSIUM | HF Acquisition Co LLC, DBA HealthFirst | 50c7500f-be06-01af-e063-6294a90a0135 | 2026-05-01 | Warnings, Adverse reactions | VL775ZTH4C |
| Pfizerpen | PENICILLIN G POTASSIUM | Roerig | efef4846-9497-41af-8dd6-518f86eca7f2 | 2025-12-16 | Warnings, Adverse reactions | VL775ZTH4C |
| Penicillin G Potassium | PENICILLIN G POTASSIUM | Avenacy Inc. | 969a421e-37d8-499e-9e89-67e210bd5d9d | 2025-02-01 | Warnings, Adverse reactions | VL775ZTH4C |
| Penicillin G Potassium | PENICILLIN G POTASSIUM | Athenex Pharmaceutical Division, LLC. | 1442486a-05d6-4dce-8b95-857a30f478c2 | 2025-01-28 | Warnings, Adverse reactions | VL775ZTH4C |
| Pfizerpen | PENICILLIN G POTASSIUM | Roerig | 2f7ea103-56cc-492f-b862-af45f9aed980 | 2024-12-12 | Warnings, Adverse reactions | VL775ZTH4C |
| Pfizerpen | PENICILLIN G POTASSIUM | Roerig | d8aaefb6-3f7d-4bc5-b40a-1c58c3054320 | 2024-12-10 | Warnings, Adverse reactions | VL775ZTH4C |
| Penicillin G Potassium | PENICILLIN G POTASSIUM | Sagent Pharmaceuticals | fb2f3afe-0072-4383-bad8-9da9e94db4f2 | 2024-12-04 | Warnings, Adverse reactions | VL775ZTH4C |
| Penicillin G Potassium | PENICILLIN G POTASSIUM | NorthStar Rx, LLC | 8732b7ff-2e47-4f99-aadf-81861b431f4f | 2024-06-28 | Warnings, Adverse reactions | VL775ZTH4C |
| Penicillin G Potassium | PENICILLIN G POTASSIUM | Sandoz Inc | 91950983-4884-40d1-abd8-bcc953d61b7f | 2020-09-16 | Warnings, Adverse reactions | VL775ZTH4C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.